Amicus Therapeutics Canada
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 King St W, Toronto, Ontario, M5X 1G5...Phone Number
(514) 426-6261Website
www.amicustherapeutics.caRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Amicus Therapeutics Canada
Amicus Therapeutics is a biotechnology company headquartered in the USA that develops treatments for human genetic diseases. A wholly owned subsidiary of BioMarin Pharmaceutical Inc., the company focuses on delivering high-quality therapies for persons living with rare, orphan, and metabolic diseases. It leverages innovative technology platforms to advance a pipeline of first- or best-in-class medicines designed to provide meaningful benefits to patients and their families.Explore more
Popular SearchesAmicus Therapeutics Canada IncAmicus Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amicus Therapeutics Canada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Amicus Therapeutics Canada launches new products
Amicus Therapeutics Canada, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Amicus Therapeutics Canada
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Amicus Therapeutics Canada had a recent Job posting/layoffs
Earning: See what the market has to say on Amicus Therapeutics Canada recently announced quarterly report
Check out if Amicus Therapeutics Canada is spiking on competitors!
Check if Amicus Therapeutics Canada has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Amicus Therapeutics Canada has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Amicus Therapeutics Canada
Compare insights from companies similar to Amicus Therapeutics Canada, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Amicus Therapeutics Canad...
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Amicus Therapeutics Canada is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amicus Therapeutics Canada is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amicus Therapeutics Canada.
Amicus Therapeutics Canada Tech Stack
A closer look at the technologies used by Amicus Therapeutics Canada
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Amicus Therapeutics Canada
Sign Up For FreeTo access detailed company insights
Amicus Therapeutics is a biotechnology company headquartered in the USA that develops treatments for human genetic diseases. A wholly owned subsidiary of BioMarin Pharmaceutical Inc., the company focuses on delivering high-quality therapies for persons living with rare, orphan, and metabolic diseases. It leverages innovative technology platforms to... Read More
